NCT06309212

Brief Summary

Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,197

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2023

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 12, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

15 days

First QC Date

March 12, 2024

Last Update Submit

March 12, 2024

Conditions

Keywords

AdultsHuman metapneumovirusPost-COVID-19 eraPrevalenceUnderestimated Virus

Outcome Measures

Primary Outcomes (1)

  • Prevalence of HMPV infection in adults pre- and post-COVID-19 pandemic

    Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay

    Between 2016-2020 (pre-COVID) and 2021-2023 (post-COVID)

Secondary Outcomes (1)

  • Comparison of HMPV with other respiratory viruses in adults

    Between 2016-2020 (pre-COVID) and 2021-2023 (post-COVID)

Study Arms (2)

Pre-COVID period

January 2016 to January 2020

Other: Observation

Post-COVID period

January 2021 to September 2023

Other: Observation

Interventions

Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay

Post-COVID periodPre-COVID period

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This retrospective study examined adults with acute respiratory tract infections in Istanbul, Turkey. Patients admitted between 2016-2020 (pre-COVID) and 2021-2023 (post-COVID) underwent multiplex PCR testing for various respiratory viruses, with a focus on human metapneumovirus. The study aimed to assess the prevalence of HMPV infection in adults and its potential change after the COVID-19 pandemic.

You may qualify if:

  • Adults \>18 years
  • Patients with acute respiratory tract infection symptoms
  • Patients who underwent multiplex PCR testing for respiratory viruses

You may not qualify if:

  • Patients for whom no respiratory viral panel test was conducted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acibadem University

Istanbul, Turkey (Türkiye)

Location

Related Publications (5)

  • Niederman MS, Torres A. Respiratory infections. Eur Respir Rev. 2022 Oct 19;31(166):220150. doi: 10.1183/16000617.0150-2022. Print 2022 Dec 31.

    PMID: 36261160BACKGROUND
  • Haas LE, Thijsen SF, van Elden L, Heemstra KA. Human metapneumovirus in adults. Viruses. 2013 Jan 8;5(1):87-110. doi: 10.3390/v5010087.

    PMID: 23299785BACKGROUND
  • Boivin G, De Serres G, Hamelin ME, Cote S, Argouin M, Tremblay G, Maranda-Aubut R, Sauvageau C, Ouakki M, Boulianne N, Couture C. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis. 2007 May 1;44(9):1152-8. doi: 10.1086/513204. Epub 2007 Mar 28.

    PMID: 17407031BACKGROUND
  • Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023 Mar;21(3):195-210. doi: 10.1038/s41579-022-00807-9. Epub 2022 Oct 17.

    PMID: 36253478BACKGROUND
  • Pearson V. Case studies. Baton Rouge puts community first. Trustee. 1995 May;48(5):24-6. No abstract available.

    PMID: 10142898BACKGROUND

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2024

First Posted

March 13, 2024

Study Start

December 15, 2023

Primary Completion

December 30, 2023

Study Completion

January 30, 2024

Last Updated

March 13, 2024

Record last verified: 2024-03

Locations